Capital Fund Management (CFM)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-26,563
| Closed | -$5.21M | – | 2151 |
|
|
2026
Q1 | $5.21M | Buy |
+26,563
| New | +$5.16M | 0.02% | 874 |
|
|
2025
Q4 | – | Sell |
-47,875
| Closed | -$8.72M | – | 2427 |
|
|
2025
Q3 | $9.12M | Buy |
47,875
+18,241
| +62% | +$3.24M | 0.02% | 884 |
|
|
2025
Q2 | $5.32M | Buy |
29,634
+19,305
| +187% | +$3.35M | 0.01% | 1104 |
|
|
2025
Q1 | $1.75M | Buy |
+10,329
| New | +$1.7M | 0.01% | 1473 |
|
|
2024
Q3 | – | Sell |
-22,072
| Closed | -$3.02M | – | 2007 |
|
|
2024
Q2 | $3.02M | Buy |
+22,072
| New | +$3.02M | 0.01% | 1205 |
|
|
2022
Q3 | – | Sell |
-14,572
| Closed | -$1.94M | – | 1456 |
|
|
2022
Q2 | $1.94M | Sell |
14,572
-12,556
| -46% | -$1.71M | 0.02% | 838 |
|
|
2022
Q1 | $3.71M | Buy |
27,128
+16,836
| +164% | +$2.35M | 0.03% | 689 |
|
|
2021
Q4 | $1.78M | Sell |
10,292
-22,845
| -69% | -$3.48M | 0.01% | 1084 |
|
|
2021
Q3 | $4.82M | Buy |
+33,137
| New | +$4.85M | 0.04% | 597 |
|
|
2020
Q4 | – | Sell |
-13,966
| Closed | -$1.7M | – | 1332 |
|
|
2020
Q3 | $1.6M | Buy |
+13,966
| New | +$1.65M | 0.02% | 709 |
|
|
2020
Q2 | – | Sell |
-9,004
| Closed | -$955K | – | 1145 |
|
|
2020
Q1 | $723K | Buy |
9,004
+7,104
| +374% | +$735K | 0.01% | 912 |
|
|
2019
Q4 | $203K | Sell |
1,900
-5,189
| -73% | -$541K | ﹤0.01% | 1751 |
|
|
2019
Q3 | $759K | Buy |
+7,089
| New | +$728K | 0.01% | 1100 |
|
|
2019
Q2 | – | Sell |
-30,650
| Closed | -$2.95M | – | 1661 |
|
|
2019
Q1 | $2.76M | Buy |
+30,650
| New | +$2.66M | 0.02% | 689 |
|
|
2018
Q4 | – | Sell |
-26,248
| Closed | -$2.83M | – | 1922 |
|
|
2018
Q3 | $2.83M | Sell |
26,248
-37,682
| -59% | -$4.13M | 0.02% | 974 |
|
|
2018
Q2 | $7.03M | Sell |
63,930
-285,100
| -82% | -$29.7M | 0.04% | 589 |
|
|
2018
Q1 | $35M | Sell |
349,030
-14,100
| -4% | -$1.44M | 0.21% | 123 |
|
|
2017
Q4 | $35.8M | Buy |
363,130
+275,800
| +316% | +$26.1M | 0.2% | 128 |
|
|
2017
Q3 | $8.18M | Buy |
87,330
+53,068
| +155% | +$5.63M | 0.06% | 391 |
|
|
2017
Q2 | $3.81M | Sell |
34,262
-8,952
| -21% | -$947K | 0.03% | 556 |
|
|
2017
Q1 | $4.24M | Buy |
+43,214
| New | +$4.12M | 0.04% | 537 |
|
|
2016
Q4 | – | Sell |
-124,467
| Closed | -$10.7M | – | 1685 |
|
|
2016
Q3 | $10.5M | Buy |
124,467
+120,720
| +3,222% | +$10.1M | 0.1% | 256 |
|
|
2016
Q2 | $305K | Sell |
3,747
-42,952
| -92% | -$3.27M | ﹤0.01% | 1324 |
|
|
2016
Q1 | $3.34M | Buy |
+46,699
| New | +$3.13M | 0.03% | 554 |
|
|
2015
Q4 | – | Sell |
-7,431
| Closed | -$500K | – | 1587 |
|
|
2015
Q3 | $457K | Buy |
+7,431
| New | +$519K | 0.01% | 1073 |
|
|
2015
Q1 | – | Sell |
-14,020
| Closed | -$1M | – | 1503 |
|
|
2014
Q4 | $940K | Buy |
+14,020
| New | +$885K | 0.01% | 907 |
|
|
2014
Q3 | – | Sell |
-9,441
| Closed | -$554K | – | 1570 |
|
|
2014
Q2 | $554K | Sell |
9,441
-155,200
| -94% | -$9.09M | 0.01% | 1182 |
|
|
2014
Q1 | $9.54M | Buy |
164,641
+160,571
| +3,945% | +$8.61M | 0.12% | 208 |
|
|
2013
Q4 | $218K | Buy |
+4,070
| New | +$241K | ﹤0.01% | 1555 |
|
|
2013
Q3 | – | Sell |
-7,247
| Closed | -$439K | – | 1638 |
|
|
2013
Q2 | $439K | Buy |
+7,247
| New | +$432K | 0.01% | 1036 |
|
Other funds holding DGX
EIG
Capital Fund Management (CFM)'s DGX Position: Q2 2026 in Review
Capital Fund Management (CFM) sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 26,563 shares — an estimated $5.21M sold.
Capital Fund Management (CFM) first reported a position in DGX in Q2 2013 and held it in 30 quarters. The position peaked at $35.8M in Q4 2017. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Capital Fund Management (CFM) reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
- Capital Fund Management (CFM) sold 26,563 Quest Diagnostics shares in Q2 2026, an estimated $5.21M.
- Capital Fund Management (CFM) first reported a position in Quest Diagnostics in Q2 2013 and held it in 30 quarters.
- Capital Fund Management (CFM)'s Quest Diagnostics position peaked at $35.8M in Q4 2017.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.